Katherine Modzelewski, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Katherine L. Modzelewski, MD, is an Assistant Professor of Medicine at the Boston University Chobanian & Avedisian School of Medicine and a practicing clinical endocrinologist in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Boston Medical Center. She completed her residency in Internal Medicine and fellowship in Endocrinology at Boston Medical Center, where she serves as an Associate Program Director for the Internal Medicine Residency. She is also the co-director of the Inpatient Diabetes Program at Boston Medical Center. Her clinical interests include type 1 and type 2 diabetes, diabetes technology and gender affirming care. Clinical research interests include diabetes outcomes, endocrine fellowship training in diabetes technology, and technology usage in underserved populations.

Publications

  • Published 12/18/2025

    Ferri GM, Anderson REP, Fadel OE, Nguyen T, Vora A, Davis DN, Bosch NA, Modzelewski KL. Association between absolute eosinophil count and outcomes in sickle cell disease vaso-occlusive episodes. Blood Red Cells Iron. 2026 Mar; 2(1). PMID: 42375134.

    Read at: PubMed

  • Published 6/17/2025

    Suarez S, Lupton Lupez E, Modzelewski KL, Hinkle C, Streed CG, Siegel J. A Systematic and Practical Framework on Gender and Sexual Diverse (GSD) Health for Internal Medicine Residents. MedEdPORTAL. 2025; 21:11535. PMID: 40530167.

    Read at: PubMed

  • Published 8/24/2024

    Siskind SM, Yadav S, Solomon M, Knapp PE, Menn-Josephy H, Francis J, Rennke HG, Ayalon R, Modzelewski KL. Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer. AACE Clin Case Rep. 2024; 10(6):244-248. PMID: 39734505.

    Read at: PubMed

  • Published 5/1/2024

    Siskind SM, Johnson TY, Klings ES, Modzelewski KL. Diabetes Screening Rates and Practices in Patients With Sickle Cell Disease. Diabetes Care. 2024 May 01; 47(5):e42-e43. PMID: 38489046.

    Read at: PubMed

  • Published 5/1/2024

    Modzelewski KL, Pipilas A, Bosch NA. Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure. JAMA Netw Open. 2024 May 01; 7(5):e249305. PMID: 38696170.

    Read at: PubMed

Education

  • New York Medical College, MD
  • Boston College, BS